CT based radiomic approach on first line pembrolizumab in lung cancer
Abstract Clinical evaluation poorly predicts outcomes in lung cancer treated with immunotherapy. The aim of the study is to assess whether CT-derived texture parameters can predict overall survival (OS) and progression-free survival (PFS) in patients with advanced non-small-cell lung cancer (NSCLC)...
Saved in:
Main Authors: | Marta Zerunian, Damiano Caruso, Alberto Zucchelli, Michela Polici, Carlo Capalbo, Marco Filetti, Federica Mazzuca, Paolo Marchetti, Andrea Laghi |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/18a7ae47de7d4a85ad1c5f7dd80511e2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness analysis of pembrolizumab plus chemotherapy as first-line therapy for extensive-stage small-cell lung cancer.
by: Qiao Liu, et al.
Published: (2021) -
Cost-effectiveness analysis of pembrolizumab plus chemotherapy as first-line therapy for extensive-stage small-cell lung cancer
by: Qiao Liu, et al.
Published: (2021) -
Pembrolizumab or Bevacizumab Plus Chemotherapy as First-Line Treatment of Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Retrospective Cohort Study
by: Jie Zhang PhD, et al.
Published: (2021) -
Radiomics-guided deep neural networks stratify lung adenocarcinoma prognosis from CT scans
by: Hwan-ho Cho, et al.
Published: (2021) -
Differentiating Central Lung Tumors from Atelectasis with Contrast-Enhanced CT-Based Radiomics Features
by: Rui Chai, et al.
Published: (2021)